ATG5 and neoplasm: Here, the researchers generated mice that expressed oncogenic KRAS in pancreatic cells and had either homozygous, heterozygous or no disruption of Atg5. Unexpectedly, it was observed that reduced ATG5 protein levels promote tumor development, whereas homozygous disruption of Atg5 blocks tumorigenesis [24].